Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Arch Neurol. 2012 May;69(5):567–571. doi: 10.1001/archneurol.2011.977

Figure 2.

Figure 2

Spectrum of measures available for the study of dementia and cognitive decline in three generations of the Framingham Heart Study: risk factors, genome-wide association studies, biomarkers, preclinical indicators and change in cognitive function and brain morphology, and neuropathological examination.